Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00608582 · ClinicalTrials.gov registry record · Phase 1
Transcranial Magnetic Stimulation to Improve Speech in Aphasia
A Phase 1 study, sponsored by Boston University.
- Completed
- Registry status
- Phase 1
- Development phase
- 63
- Enrollment target
NCT00608582 is a Phase 1 study that has completed, run by Boston University. The registered enrollment target is 63 participants.
The verdict
NCT00608582, a Phase 1 study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 63 participants
- Enrollment target
Study Summary
The purpose of this study is to examine whether repetitive transcranial magnetic stimulation (rTMS) can be used to improve speech in chronic stroke patients with aphasia. Aphasia patients can have problems with speech production. The rTMS procedure allows painless, noninvasive stimulation of human cortex from outside the head. Chronic aphasia patients have been observed in our functional magnetic resonance brain imaging studies to have excess brain activation in brain areas possibly related to language on the right side of the brain (opposite side to where the stroke took place). It is expected that suppression of activity in the directly targeted brain region will have an overall modulating effect on the neural network for naming (and propositional speech) and will result in behavioral improvement.
Interventions
- DEVICE Transcranial Magnetic Stimulation, Repetitive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2002-07 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00608582
The ClinicalTrials.gov registry entry for NCT00608582 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial Magnetic Stimulation, Repetitive is the first listed.
NCT00608582 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00608582 about?
NCT00608582 is a clinical study titled "Transcranial Magnetic Stimulation to Improve Speech in Aphasia". The purpose of this study is to examine whether repetitive transcranial magnetic stimulation (rTMS) can be used to improve speech in chronic stroke patients with aphasia. Aphasia patients can have problems with speech production. The rTMS procedure allows painless, noninvasive stimulation of human c...
What is the current status of trial NCT00608582?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 63 participants. The study started on 2002-07. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00608582?
The interventions under investigation include: Transcranial Magnetic Stimulation, Repetitive (DEVICE).
Who is sponsoring clinical trial NCT00608582?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.